HighVista Strategies LLC

Position in GPCR — Structure Therapeutics Inc.

CIK 1335325 BOSTON, MA

Position in GPCR

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$5,972,413

-$7,450,806 QoQ

Shares Held

123,909

-35.8% QoQ

Ownership

0.058%

of shares outstanding

% of Portfolio

1.66%

of 13F equity value

Holder Rank

#60

of 196 holders

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

HighVista Strategies LLC holds $224,607,258 across 76 Biotechnology names. GPCR ranks #8 (2.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABVX	Abivax S.A.	113,254	$12,610,832
2	PRAX	Praxis Precision Medicines, Inc.	26,323	$8,481,007
3	COGT	Cogent Biosciences, Inc.	197,051	$7,584,492
4	SYRE	Spyre Therapeutics, Inc.	146,264	$7,377,556
5	PCVX	Vaxcyte, Inc.	124,647	$7,243,237
6	RVMD	Revolution Medicines, Inc.	69,309	$6,740,300
7	TERN	Terns Pharmaceuticals, Inc.	114,307	$6,026,265
8	GPCR	Structure Therapeutics Inc. This page	123,909	$5,972,413

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$5,972,413	123,909	-35.8%	Shares	Sole	2026-05-15
2025-12-31	$13,423,219	193,001	-18.3%	Shares	Sole	2026-02-17
2025-09-30	$6,614,608	236,236	+172.7%	Shares	Sole	2025-11-14
2025-06-30	$1,796,519	86,621	+393.3%	Shares	Sole	2025-08-14
2025-03-31	$303,980	17,561	0.0%	Shares	Sole	2025-05-15
2024-12-31	$476,254	17,561	-44.6%	Shares	Sole	2025-02-14
2024-09-30	$1,392,103	31,718	-9.7%	Shares	Sole	2024-11-14
2024-06-30	$1,379,476	35,128	-6.2%	Shares	Sole	2024-08-14
2024-03-31	$1,604,849	37,444	-50.0%	Shares	Sole	2024-05-15
2023-12-31	$3,050,152	74,832	0.0%	Shares	Sole	2024-02-14
2023-09-30	$3,773,029	74,832	—	Shares	Sole	2023-11-14
No filing history on record for this holder in this stock.